Cerity Partners LLC Tekla Life Sciences Investors Transaction History

Cerity Partners LLC

$44.7 Billion
Q3 2024

Shares

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2023 Jan 26, 2024	BUY	$11.35 - $13.6 $177,150 - $212,268	15,608 New	15,608 $210,000
Q2 2023 Aug 14, 2023	BUY	$13.13 - $14.17 $241,697 - $260,841	18,408 New	18,408 $249,000
Q2 2018 Aug 15, 2018	SELL	$18.13 - $19.4 $181,300 - $194,000	-10,000 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$18.92 - $21.52 $189,200 - $215,200	10,000 New	10,000 $192,000
Q4 2017 Feb 14, 2018	SELL	$18.31 - $22.24 $183,100 - $222,399	-10,000 Closed	0 $0
Q3 2017 Nov 13, 2017	BUY	$20.12 - $21.88 $201,200 - $218,800	10,000	10,000 $215,000

Others Institutions Holding HQL

# of Institutions

75

Shares Held

9.29M

Call Options Held

0

Put Options Held

0

Saba Capital Management, L.P. New York, NY

3.43M
Shares

$47.3 Million
1.1% of portfolio
Penserra Capital Management LLC Orinda, CA

776K
Shares

$10.7 Million
0.25% of portfolio
Morgan Stanley New York, NY

490K
Shares

$6.75 Million
0.0% of portfolio
Karpus Management, Inc. Pittsford, NY

469K
Shares

$6.46 Million
0.23% of portfolio
Sit Investment Associates Inc Minneapolis, MN

417K
Shares

$5.75 Million
0.14% of portfolio

About TEKLA LIFE SCIENCES INVESTORS

Ticker HQL
Exchange NYSE
Sector Financial Services
Industry Asset Management
Description
Tekla Life Sciences Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical...

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cerity Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cerity Partners LLC with notifications on news.